Hear from MedImmune and Ipsen at SMi’s Injectable Drug Delivery 2018

London, United Kingdom, February 07, 2018 --(PR.com)-- The opening Keynote Address on day 1 will be presented by Dr. Anand Subramony, Vice President, Novel Product Technologies, from MedImmune, where he will explore the emerging trends and opportunities in drug development. Anand’s focus is to maintain state of the art innovation through cross functional collaboration and bringing in cutting edge external based technology, leading the team to produce innovative drug delivery and device technologies.

Anand Subramony is Vice President of Novel Product Technologies at MedImmune, the global biological arm of AstraZeneca. In this role, Dr. Subramony heads the function from the CTO office and oversees efforts in creating patient centric products that rely on the principles of digital health, connected drug-device combination products and other novel drug delivery technologies including diagnostics and sensors.

Below is a summary of Dr. Subramony's presentation:

Opening Keynote Address: Drug Delivery: Emerging trends and opportunities - Day 1 | 09:10

- A look at how fast the delivery technology field has evolved until now – factors that will contribute to continued development
- Discussing the future of evolving areas including polymer technologies, auto injectors, microneedles etc
- Learnings and Opportunities

The opening Keynote Address on day 2 will be presented by Joel Richard, Senior Vice President, Peptides Development, from Ipsen, where he will examine how companies can develop better biologics via peptide delivery. Dr Joel Richard is currently Senior Vice President, Peptides in IPSEN (France). He is globally leading all the pharmaceutical development activities of both injectable and oral peptide-based products, including APIs and drug products, with major franchises in Oncology, Endocrinology and Neurology. Dr Richard has more than 25 years of experience in chemistry and biopharmaceutical R&D, including several global senior positions in various Biotech and Pharma companies.

Below is a summary of Dr. Richard's presentation:

Opening Keynote Address: Injectable Peptide Delivery: How can Nanosystems Help Address Present and Future Challenges - Day 2 | 09:10

- Peptide therapeutic landscape
- Injectable peptide sustained-release (SR) formulations
- Peptide delivery to the brain
- Peptide delivery to tumors and cells
- Alternative non-invasive peptide delivery routes

For those looking to attend there is currently a £200 early-bird saving, ending February 28th.

Further information is available at: www.injectable-drug-delivery.com/prc

SMi presents the Launch of:

Injectable Drug Delivery
Date: 16th – 17th May 2018
Workshops: 15th May 21018
Location: Holiday Inn Kensington Forum, London UK
Website: www.injectable-drug-delivery.com/prc

Contact Information:

For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk